Skip to main content
Premium Trial:

Request an Annual Quote

Intelligent Bio-Systems Gets $750K from Mass Accelerator Program

NEW YORK (GenomeWeb News) – Next-generation sequencing systems developer Intelligent Bio-Systems will receive $750,000 in funding through the Massachusetts Life Sciences Center's Accelerator Program, the Center said this week.

Waltham, Mass.-based Intelligent Bio-Systems is developing a next-generation DNA sequencing system and is preparing to launch a smaller, low-cost version of its platform. According to the Center, which is a quasi-public agency of the Commonwealth of Massachusetts aimed at creating growth in the state's life sciences industry, Intelligent Bio-Systems is currently focused on completing small-scale prototypes and moving its system into beat testing at customer labs.

The funding is through the Accelerator Program, which provides loans of up to $750,000 to early-stage firms to support research and proof-of-concept studies. Intelligent Bio-Systems was one of three firms to receive approval from the Center's Board of Directors for this round of loans — the other two firms were medical device firms Allurion Technologies and Paragonix Technologies.

Last year, Intelligent Bio-Systems was one of several firms to receive a grant through the National Human Genome Research Institute's Revolutionary Genome Sequencing Technologies grants program. The firm received a $2.6 million grant to continue work focused on the generation a low-cost, high-speed sequencing system that combines novel chip-making techniques with synthetic chemistry technology licensed from Columbia University.

As reported in August by GenomeWeb Daily News sister publication In Sequence, Intelligent Bio-Systems has partnered with Danaher Motion's Dover and Azco BioTech to launch the Max-Seq Genome Sequencer, a short-read DNA sequencing platform that promises high throughput at low cost.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.